Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2023 | Actym Therapeutics, Inc. | $26.0M Series A | Illumina Ventures, Boehringer Ingelheim | Boehringer Ingelheim Venture Fund, GKCC |
| Apr 1, 2020 | Actym Therapeutics, Inc. | $34.0M Series A | Kanad Das | Boehringer Ingelheim Venture Fund, Illumina Ventures, Korea Investment Partners |